Global Point-of-Care Infectious Disease Diagnostics & Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Point-of-Care Infectious Disease Diagnostics & Testing market size was valued at USD 2113.1 million in 2023 and is forecast to a readjusted size of USD 2820.3 million by 2030 with a CAGR of 4.2% during review period.
A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Point-of-Care Infectious Disease Diagnostics & Testing industry chain, the market status of Hospitals (HIV POC, Clostridium difficile POC), Clinics (HIV POC, Clostridium difficile POC), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Point-of-Care Infectious Disease Diagnostics & Testing.
Regionally, the report analyzes the Point-of-Care Infectious Disease Diagnostics & Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Point-of-Care Infectious Disease Diagnostics & Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Point-of-Care Infectious Disease Diagnostics & Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Point-of-Care Infectious Disease Diagnostics & Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., HIV POC, Clostridium difficile POC).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Point-of-Care Infectious Disease Diagnostics & Testing market.
Regional Analysis: The report involves examining the Point-of-Care Infectious Disease Diagnostics & Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Point-of-Care Infectious Disease Diagnostics & Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Point-of-Care Infectious Disease Diagnostics & Testing:
Company Analysis: Report covers individual Point-of-Care Infectious Disease Diagnostics & Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Point-of-Care Infectious Disease Diagnostics & Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Point-of-Care Infectious Disease Diagnostics & Testing. It assesses the current state, advancements, and potential future developments in Point-of-Care Infectious Disease Diagnostics & Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Point-of-Care Infectious Disease Diagnostics & Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Point-of-Care Infectious Disease Diagnostics & Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Point-of-Care Infectious Disease Diagnostics & Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Point-of-Care Infectious Disease Diagnostics & Testing, with revenue, gross margin and global market share of Point-of-Care Infectious Disease Diagnostics & Testing from 2019 to 2024.
Chapter 3, the Point-of-Care Infectious Disease Diagnostics & Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Point-of-Care Infectious Disease Diagnostics & Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Point-of-Care Infectious Disease Diagnostics & Testing.
Chapter 13, to describe Point-of-Care Infectious Disease Diagnostics & Testing research findings and conclusion.
A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Point-of-Care Infectious Disease Diagnostics & Testing industry chain, the market status of Hospitals (HIV POC, Clostridium difficile POC), Clinics (HIV POC, Clostridium difficile POC), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Point-of-Care Infectious Disease Diagnostics & Testing.
Regionally, the report analyzes the Point-of-Care Infectious Disease Diagnostics & Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Point-of-Care Infectious Disease Diagnostics & Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Point-of-Care Infectious Disease Diagnostics & Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Point-of-Care Infectious Disease Diagnostics & Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., HIV POC, Clostridium difficile POC).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Point-of-Care Infectious Disease Diagnostics & Testing market.
Regional Analysis: The report involves examining the Point-of-Care Infectious Disease Diagnostics & Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Point-of-Care Infectious Disease Diagnostics & Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Point-of-Care Infectious Disease Diagnostics & Testing:
Company Analysis: Report covers individual Point-of-Care Infectious Disease Diagnostics & Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Point-of-Care Infectious Disease Diagnostics & Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Clinics).
Technology Analysis: Report covers specific technologies relevant to Point-of-Care Infectious Disease Diagnostics & Testing. It assesses the current state, advancements, and potential future developments in Point-of-Care Infectious Disease Diagnostics & Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Point-of-Care Infectious Disease Diagnostics & Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Point-of-Care Infectious Disease Diagnostics & Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- HIV POC
- Clostridium difficile POC
- HBV POC
- Pneumonia or Streptococcus associated infections
- Respiratory syncytial virus (RSV) POC
- HPV POC
- Influenza/Flu POC
- Other Infectious Disease POC
- Hospitals
- Clinics
- Home
- Assisted Living Healthcare Facilities
- Laboratories
- Others
- Abbott
- Thermo Fisher Scientific Inc
- Roche
- Siemens Healthineers
- BD & Company
- Chembio Diagnostics Inc.
- Trinity Biotech
- Cardinal Health
- Quest Diagnostics Inc.
- Bio-Rad Labs Inc.
- bioMйrieux SA
- Sight Diagnostics Ltd.
- Gene POC
- Trivitron Healthcare
- OJ-Bio Ltd.
- Ortho-Clinical Diagnostics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Point-of-Care Infectious Disease Diagnostics & Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Point-of-Care Infectious Disease Diagnostics & Testing, with revenue, gross margin and global market share of Point-of-Care Infectious Disease Diagnostics & Testing from 2019 to 2024.
Chapter 3, the Point-of-Care Infectious Disease Diagnostics & Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Point-of-Care Infectious Disease Diagnostics & Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Point-of-Care Infectious Disease Diagnostics & Testing.
Chapter 13, to describe Point-of-Care Infectious Disease Diagnostics & Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Point-of-Care Infectious Disease Diagnostics & Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Point-of-Care Infectious Disease Diagnostics & Testing by Type
1.3.1 Overview: Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Type in 2023
1.3.3 HIV POC
1.3.4 Clostridium difficile POC
1.3.5 HBV POC
1.3.6 Pneumonia or Streptococcus associated infections
1.3.7 Respiratory syncytial virus (RSV) POC
1.3.8 HPV POC
1.3.9 Influenza/Flu POC
1.3.10 Other Infectious Disease POC
1.4 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by Application
1.4.1 Overview: Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Home
1.4.5 Assisted Living Healthcare Facilities
1.4.6 Laboratories
1.4.7 Others
1.5 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size & Forecast
1.6 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast by Region
1.6.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region, (2019-2030)
1.6.3 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Prospect (2019-2030)
1.6.6 South America Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.1.4 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Thermo Fisher Scientific Inc
2.2.1 Thermo Fisher Scientific Inc Details
2.2.2 Thermo Fisher Scientific Inc Major Business
2.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.2.4 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Thermo Fisher Scientific Inc Recent Developments and Future Plans
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.3.4 Roche Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Roche Recent Developments and Future Plans
2.4 Siemens Healthineers
2.4.1 Siemens Healthineers Details
2.4.2 Siemens Healthineers Major Business
2.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.4.4 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Siemens Healthineers Recent Developments and Future Plans
2.5 BD & Company
2.5.1 BD & Company Details
2.5.2 BD & Company Major Business
2.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.5.4 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 BD & Company Recent Developments and Future Plans
2.6 Chembio Diagnostics Inc.
2.6.1 Chembio Diagnostics Inc. Details
2.6.2 Chembio Diagnostics Inc. Major Business
2.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.6.4 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Chembio Diagnostics Inc. Recent Developments and Future Plans
2.7 Trinity Biotech
2.7.1 Trinity Biotech Details
2.7.2 Trinity Biotech Major Business
2.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.7.4 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Trinity Biotech Recent Developments and Future Plans
2.8 Cardinal Health
2.8.1 Cardinal Health Details
2.8.2 Cardinal Health Major Business
2.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.8.4 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Cardinal Health Recent Developments and Future Plans
2.9 Quest Diagnostics Inc.
2.9.1 Quest Diagnostics Inc. Details
2.9.2 Quest Diagnostics Inc. Major Business
2.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.9.4 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Quest Diagnostics Inc. Recent Developments and Future Plans
2.10 Bio-Rad Labs Inc.
2.10.1 Bio-Rad Labs Inc. Details
2.10.2 Bio-Rad Labs Inc. Major Business
2.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.10.4 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Bio-Rad Labs Inc. Recent Developments and Future Plans
2.11 bioMйrieux SA
2.11.1 bioMйrieux SA Details
2.11.2 bioMйrieux SA Major Business
2.11.3 bioMйrieux SA Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.11.4 bioMйrieux SA Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 bioMйrieux SA Recent Developments and Future Plans
2.12 Sight Diagnostics Ltd.
2.12.1 Sight Diagnostics Ltd. Details
2.12.2 Sight Diagnostics Ltd. Major Business
2.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.12.4 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Sight Diagnostics Ltd. Recent Developments and Future Plans
2.13 Gene POC
2.13.1 Gene POC Details
2.13.2 Gene POC Major Business
2.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.13.4 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Gene POC Recent Developments and Future Plans
2.14 Trivitron Healthcare
2.14.1 Trivitron Healthcare Details
2.14.2 Trivitron Healthcare Major Business
2.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.14.4 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Trivitron Healthcare Recent Developments and Future Plans
2.15 OJ-Bio Ltd.
2.15.1 OJ-Bio Ltd. Details
2.15.2 OJ-Bio Ltd. Major Business
2.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.15.4 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 OJ-Bio Ltd. Recent Developments and Future Plans
2.16 Ortho-Clinical Diagnostics
2.16.1 Ortho-Clinical Diagnostics Details
2.16.2 Ortho-Clinical Diagnostics Major Business
2.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.16.4 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Ortho-Clinical Diagnostics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Point-of-Care Infectious Disease Diagnostics & Testing by Company Revenue
3.2.2 Top 3 Point-of-Care Infectious Disease Diagnostics & Testing Players Market Share in 2023
3.2.3 Top 6 Point-of-Care Infectious Disease Diagnostics & Testing Players Market Share in 2023
3.3 Point-of-Care Infectious Disease Diagnostics & Testing Market: Overall Company Footprint Analysis
3.3.1 Point-of-Care Infectious Disease Diagnostics & Testing Market: Region Footprint
3.3.2 Point-of-Care Infectious Disease Diagnostics & Testing Market: Company Product Type Footprint
3.3.3 Point-of-Care Infectious Disease Diagnostics & Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2030)
6.2 North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2030)
6.3 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country
6.3.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2019-2030)
6.3.2 United States Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2030)
7.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2030)
7.3 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country
7.3.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
7.3.3 France Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region
8.3.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Region (2019-2030)
8.3.2 China Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
8.3.5 India Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2030)
9.2 South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2030)
9.3 South America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country
9.3.1 South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country
10.3.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Point-of-Care Infectious Disease Diagnostics & Testing Market Drivers
11.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Restraints
11.3 Point-of-Care Infectious Disease Diagnostics & Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Point-of-Care Infectious Disease Diagnostics & Testing Industry Chain
12.2 Point-of-Care Infectious Disease Diagnostics & Testing Upstream Analysis
12.3 Point-of-Care Infectious Disease Diagnostics & Testing Midstream Analysis
12.4 Point-of-Care Infectious Disease Diagnostics & Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Point-of-Care Infectious Disease Diagnostics & Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Point-of-Care Infectious Disease Diagnostics & Testing by Type
1.3.1 Overview: Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Type in 2023
1.3.3 HIV POC
1.3.4 Clostridium difficile POC
1.3.5 HBV POC
1.3.6 Pneumonia or Streptococcus associated infections
1.3.7 Respiratory syncytial virus (RSV) POC
1.3.8 HPV POC
1.3.9 Influenza/Flu POC
1.3.10 Other Infectious Disease POC
1.4 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by Application
1.4.1 Overview: Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Home
1.4.5 Assisted Living Healthcare Facilities
1.4.6 Laboratories
1.4.7 Others
1.5 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size & Forecast
1.6 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast by Region
1.6.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region, (2019-2030)
1.6.3 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Prospect (2019-2030)
1.6.6 South America Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.1.4 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Thermo Fisher Scientific Inc
2.2.1 Thermo Fisher Scientific Inc Details
2.2.2 Thermo Fisher Scientific Inc Major Business
2.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.2.4 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Thermo Fisher Scientific Inc Recent Developments and Future Plans
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.3.4 Roche Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Roche Recent Developments and Future Plans
2.4 Siemens Healthineers
2.4.1 Siemens Healthineers Details
2.4.2 Siemens Healthineers Major Business
2.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.4.4 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Siemens Healthineers Recent Developments and Future Plans
2.5 BD & Company
2.5.1 BD & Company Details
2.5.2 BD & Company Major Business
2.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.5.4 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 BD & Company Recent Developments and Future Plans
2.6 Chembio Diagnostics Inc.
2.6.1 Chembio Diagnostics Inc. Details
2.6.2 Chembio Diagnostics Inc. Major Business
2.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.6.4 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Chembio Diagnostics Inc. Recent Developments and Future Plans
2.7 Trinity Biotech
2.7.1 Trinity Biotech Details
2.7.2 Trinity Biotech Major Business
2.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.7.4 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Trinity Biotech Recent Developments and Future Plans
2.8 Cardinal Health
2.8.1 Cardinal Health Details
2.8.2 Cardinal Health Major Business
2.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.8.4 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Cardinal Health Recent Developments and Future Plans
2.9 Quest Diagnostics Inc.
2.9.1 Quest Diagnostics Inc. Details
2.9.2 Quest Diagnostics Inc. Major Business
2.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.9.4 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Quest Diagnostics Inc. Recent Developments and Future Plans
2.10 Bio-Rad Labs Inc.
2.10.1 Bio-Rad Labs Inc. Details
2.10.2 Bio-Rad Labs Inc. Major Business
2.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.10.4 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Bio-Rad Labs Inc. Recent Developments and Future Plans
2.11 bioMйrieux SA
2.11.1 bioMйrieux SA Details
2.11.2 bioMйrieux SA Major Business
2.11.3 bioMйrieux SA Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.11.4 bioMйrieux SA Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 bioMйrieux SA Recent Developments and Future Plans
2.12 Sight Diagnostics Ltd.
2.12.1 Sight Diagnostics Ltd. Details
2.12.2 Sight Diagnostics Ltd. Major Business
2.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.12.4 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Sight Diagnostics Ltd. Recent Developments and Future Plans
2.13 Gene POC
2.13.1 Gene POC Details
2.13.2 Gene POC Major Business
2.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.13.4 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Gene POC Recent Developments and Future Plans
2.14 Trivitron Healthcare
2.14.1 Trivitron Healthcare Details
2.14.2 Trivitron Healthcare Major Business
2.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.14.4 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Trivitron Healthcare Recent Developments and Future Plans
2.15 OJ-Bio Ltd.
2.15.1 OJ-Bio Ltd. Details
2.15.2 OJ-Bio Ltd. Major Business
2.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.15.4 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 OJ-Bio Ltd. Recent Developments and Future Plans
2.16 Ortho-Clinical Diagnostics
2.16.1 Ortho-Clinical Diagnostics Details
2.16.2 Ortho-Clinical Diagnostics Major Business
2.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.16.4 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Ortho-Clinical Diagnostics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Point-of-Care Infectious Disease Diagnostics & Testing by Company Revenue
3.2.2 Top 3 Point-of-Care Infectious Disease Diagnostics & Testing Players Market Share in 2023
3.2.3 Top 6 Point-of-Care Infectious Disease Diagnostics & Testing Players Market Share in 2023
3.3 Point-of-Care Infectious Disease Diagnostics & Testing Market: Overall Company Footprint Analysis
3.3.1 Point-of-Care Infectious Disease Diagnostics & Testing Market: Region Footprint
3.3.2 Point-of-Care Infectious Disease Diagnostics & Testing Market: Company Product Type Footprint
3.3.3 Point-of-Care Infectious Disease Diagnostics & Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2030)
6.2 North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2030)
6.3 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country
6.3.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2019-2030)
6.3.2 United States Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2030)
7.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2030)
7.3 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country
7.3.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
7.3.3 France Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region
8.3.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Region (2019-2030)
8.3.2 China Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
8.3.5 India Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2030)
9.2 South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2030)
9.3 South America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country
9.3.1 South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country
10.3.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Point-of-Care Infectious Disease Diagnostics & Testing Market Drivers
11.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Restraints
11.3 Point-of-Care Infectious Disease Diagnostics & Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Point-of-Care Infectious Disease Diagnostics & Testing Industry Chain
12.2 Point-of-Care Infectious Disease Diagnostics & Testing Upstream Analysis
12.3 Point-of-Care Infectious Disease Diagnostics & Testing Midstream Analysis
12.4 Point-of-Care Infectious Disease Diagnostics & Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Abbott Company Information, Head Office, and Major Competitors
Table 6. Abbott Major Business
Table 7. Abbott Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 8. Abbott Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Abbott Recent Developments and Future Plans
Table 10. Thermo Fisher Scientific Inc Company Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Inc Major Business
Table 12. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 13. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Thermo Fisher Scientific Inc Recent Developments and Future Plans
Table 15. Roche Company Information, Head Office, and Major Competitors
Table 16. Roche Major Business
Table 17. Roche Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 18. Roche Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Roche Recent Developments and Future Plans
Table 20. Siemens Healthineers Company Information, Head Office, and Major Competitors
Table 21. Siemens Healthineers Major Business
Table 22. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 23. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Siemens Healthineers Recent Developments and Future Plans
Table 25. BD & Company Company Information, Head Office, and Major Competitors
Table 26. BD & Company Major Business
Table 27. BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 28. BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. BD & Company Recent Developments and Future Plans
Table 30. Chembio Diagnostics Inc. Company Information, Head Office, and Major Competitors
Table 31. Chembio Diagnostics Inc. Major Business
Table 32. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 33. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Chembio Diagnostics Inc. Recent Developments and Future Plans
Table 35. Trinity Biotech Company Information, Head Office, and Major Competitors
Table 36. Trinity Biotech Major Business
Table 37. Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 38. Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Trinity Biotech Recent Developments and Future Plans
Table 40. Cardinal Health Company Information, Head Office, and Major Competitors
Table 41. Cardinal Health Major Business
Table 42. Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 43. Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Cardinal Health Recent Developments and Future Plans
Table 45. Quest Diagnostics Inc. Company Information, Head Office, and Major Competitors
Table 46. Quest Diagnostics Inc. Major Business
Table 47. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 48. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Quest Diagnostics Inc. Recent Developments and Future Plans
Table 50. Bio-Rad Labs Inc. Company Information, Head Office, and Major Competitors
Table 51. Bio-Rad Labs Inc. Major Business
Table 52. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 53. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Bio-Rad Labs Inc. Recent Developments and Future Plans
Table 55. bioMйrieux SA Company Information, Head Office, and Major Competitors
Table 56. bioMйrieux SA Major Business
Table 57. bioMйrieux SA Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 58. bioMйrieux SA Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. bioMйrieux SA Recent Developments and Future Plans
Table 60. Sight Diagnostics Ltd. Company Information, Head Office, and Major Competitors
Table 61. Sight Diagnostics Ltd. Major Business
Table 62. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 63. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Sight Diagnostics Ltd. Recent Developments and Future Plans
Table 65. Gene POC Company Information, Head Office, and Major Competitors
Table 66. Gene POC Major Business
Table 67. Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 68. Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Gene POC Recent Developments and Future Plans
Table 70. Trivitron Healthcare Company Information, Head Office, and Major Competitors
Table 71. Trivitron Healthcare Major Business
Table 72. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 73. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Trivitron Healthcare Recent Developments and Future Plans
Table 75. OJ-Bio Ltd. Company Information, Head Office, and Major Competitors
Table 76. OJ-Bio Ltd. Major Business
Table 77. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 78. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. OJ-Bio Ltd. Recent Developments and Future Plans
Table 80. Ortho-Clinical Diagnostics Company Information, Head Office, and Major Competitors
Table 81. Ortho-Clinical Diagnostics Major Business
Table 82. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 83. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Ortho-Clinical Diagnostics Recent Developments and Future Plans
Table 85. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million) by Players (2019-2024)
Table 86. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Share by Players (2019-2024)
Table 87. Breakdown of Point-of-Care Infectious Disease Diagnostics & Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Point-of-Care Infectious Disease Diagnostics & Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 89. Head Office of Key Point-of-Care Infectious Disease Diagnostics & Testing Players
Table 90. Point-of-Care Infectious Disease Diagnostics & Testing Market: Company Product Type Footprint
Table 91. Point-of-Care Infectious Disease Diagnostics & Testing Market: Company Product Application Footprint
Table 92. Point-of-Care Infectious Disease Diagnostics & Testing New Market Entrants and Barriers to Market Entry
Table 93. Point-of-Care Infectious Disease Diagnostics & Testing Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (USD Million) by Type (2019-2024)
Table 95. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Share by Type (2019-2024)
Table 96. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Forecast by Type (2025-2030)
Table 97. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2024)
Table 98. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Forecast by Application (2025-2030)
Table 99. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 100. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 101. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 102. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 103. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 104. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 105. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 106. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 107. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 108. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 109. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 112. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 113. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 114. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 115. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 116. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 117. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 118. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 119. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 120. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 121. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 122. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 123. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 124. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 125. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 126. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 127. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 128. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 129. Point-of-Care Infectious Disease Diagnostics & Testing Raw Material
Table 130. Key Suppliers of Point-of-Care Infectious Disease Diagnostics & Testing Raw Materials
Table 1. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Abbott Company Information, Head Office, and Major Competitors
Table 6. Abbott Major Business
Table 7. Abbott Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 8. Abbott Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Abbott Recent Developments and Future Plans
Table 10. Thermo Fisher Scientific Inc Company Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Inc Major Business
Table 12. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 13. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Thermo Fisher Scientific Inc Recent Developments and Future Plans
Table 15. Roche Company Information, Head Office, and Major Competitors
Table 16. Roche Major Business
Table 17. Roche Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 18. Roche Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Roche Recent Developments and Future Plans
Table 20. Siemens Healthineers Company Information, Head Office, and Major Competitors
Table 21. Siemens Healthineers Major Business
Table 22. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 23. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Siemens Healthineers Recent Developments and Future Plans
Table 25. BD & Company Company Information, Head Office, and Major Competitors
Table 26. BD & Company Major Business
Table 27. BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 28. BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. BD & Company Recent Developments and Future Plans
Table 30. Chembio Diagnostics Inc. Company Information, Head Office, and Major Competitors
Table 31. Chembio Diagnostics Inc. Major Business
Table 32. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 33. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Chembio Diagnostics Inc. Recent Developments and Future Plans
Table 35. Trinity Biotech Company Information, Head Office, and Major Competitors
Table 36. Trinity Biotech Major Business
Table 37. Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 38. Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Trinity Biotech Recent Developments and Future Plans
Table 40. Cardinal Health Company Information, Head Office, and Major Competitors
Table 41. Cardinal Health Major Business
Table 42. Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 43. Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Cardinal Health Recent Developments and Future Plans
Table 45. Quest Diagnostics Inc. Company Information, Head Office, and Major Competitors
Table 46. Quest Diagnostics Inc. Major Business
Table 47. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 48. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Quest Diagnostics Inc. Recent Developments and Future Plans
Table 50. Bio-Rad Labs Inc. Company Information, Head Office, and Major Competitors
Table 51. Bio-Rad Labs Inc. Major Business
Table 52. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 53. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Bio-Rad Labs Inc. Recent Developments and Future Plans
Table 55. bioMйrieux SA Company Information, Head Office, and Major Competitors
Table 56. bioMйrieux SA Major Business
Table 57. bioMйrieux SA Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 58. bioMйrieux SA Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. bioMйrieux SA Recent Developments and Future Plans
Table 60. Sight Diagnostics Ltd. Company Information, Head Office, and Major Competitors
Table 61. Sight Diagnostics Ltd. Major Business
Table 62. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 63. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Sight Diagnostics Ltd. Recent Developments and Future Plans
Table 65. Gene POC Company Information, Head Office, and Major Competitors
Table 66. Gene POC Major Business
Table 67. Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 68. Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Gene POC Recent Developments and Future Plans
Table 70. Trivitron Healthcare Company Information, Head Office, and Major Competitors
Table 71. Trivitron Healthcare Major Business
Table 72. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 73. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Trivitron Healthcare Recent Developments and Future Plans
Table 75. OJ-Bio Ltd. Company Information, Head Office, and Major Competitors
Table 76. OJ-Bio Ltd. Major Business
Table 77. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 78. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. OJ-Bio Ltd. Recent Developments and Future Plans
Table 80. Ortho-Clinical Diagnostics Company Information, Head Office, and Major Competitors
Table 81. Ortho-Clinical Diagnostics Major Business
Table 82. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 83. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Ortho-Clinical Diagnostics Recent Developments and Future Plans
Table 85. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million) by Players (2019-2024)
Table 86. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Share by Players (2019-2024)
Table 87. Breakdown of Point-of-Care Infectious Disease Diagnostics & Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Point-of-Care Infectious Disease Diagnostics & Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 89. Head Office of Key Point-of-Care Infectious Disease Diagnostics & Testing Players
Table 90. Point-of-Care Infectious Disease Diagnostics & Testing Market: Company Product Type Footprint
Table 91. Point-of-Care Infectious Disease Diagnostics & Testing Market: Company Product Application Footprint
Table 92. Point-of-Care Infectious Disease Diagnostics & Testing New Market Entrants and Barriers to Market Entry
Table 93. Point-of-Care Infectious Disease Diagnostics & Testing Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (USD Million) by Type (2019-2024)
Table 95. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Share by Type (2019-2024)
Table 96. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Forecast by Type (2025-2030)
Table 97. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2024)
Table 98. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Forecast by Application (2025-2030)
Table 99. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 100. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 101. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 102. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 103. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 104. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 105. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 106. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 107. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 108. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 109. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 112. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 113. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 114. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 115. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 116. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 117. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 118. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 119. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 120. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 121. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 122. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 123. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 124. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 125. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 126. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 127. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 128. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 129. Point-of-Care Infectious Disease Diagnostics & Testing Raw Material
Table 130. Key Suppliers of Point-of-Care Infectious Disease Diagnostics & Testing Raw Materials
LIST OF FIGURES
Figure 1. Point-of-Care Infectious Disease Diagnostics & Testing Picture
Figure 2. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Type in 2023
Figure 4. HIV POC
Figure 5. Clostridium difficile POC
Figure 6. HBV POC
Figure 7. Pneumonia or Streptococcus associated infections
Figure 8. Respiratory syncytial virus (RSV) POC
Figure 9. HPV POC
Figure 10. Influenza/Flu POC
Figure 11. Other Infectious Disease POC
Figure 12. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 13. Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Application in 2023
Figure 14. Hospitals Picture
Figure 15. Clinics Picture
Figure 16. Home Picture
Figure 17. Assisted Living Healthcare Facilities Picture
Figure 18. Laboratories Picture
Figure 19. Others Picture
Figure 20. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 21. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 22. Global Market Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 23. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Region (2019-2030)
Figure 24. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Region in 2023
Figure 25. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Share by Players in 2023
Figure 31. Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 32. Global Top 3 Players Point-of-Care Infectious Disease Diagnostics & Testing Market Share in 2023
Figure 33. Global Top 6 Players Point-of-Care Infectious Disease Diagnostics & Testing Market Share in 2023
Figure 34. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Share by Type (2019-2024)
Figure 35. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share Forecast by Type (2025-2030)
Figure 36. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Share by Application (2019-2024)
Figure 37. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share Forecast by Application (2025-2030)
Figure 38. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Type (2019-2030)
Figure 39. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Application (2019-2030)
Figure 40. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 42. Canada Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 43. Mexico Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 44. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Type (2019-2030)
Figure 45. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Application (2019-2030)
Figure 46. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 48. France Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 49. United Kingdom Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 50. Russia Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 51. Italy Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Region (2019-2030)
Figure 55. China Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 56. Japan Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 57. South Korea Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 58. India Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 59. Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 60. Australia Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 61. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Type (2019-2030)
Figure 62. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Application (2019-2030)
Figure 63. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 65. Argentina Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 66. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Type (2019-2030)
Figure 67. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Application (2019-2030)
Figure 68. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Country (2019-2030)
Figure 69. Turkey Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 71. UAE Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 72. Point-of-Care Infectious Disease Diagnostics & Testing Market Drivers
Figure 73. Point-of-Care Infectious Disease Diagnostics & Testing Market Restraints
Figure 74. Point-of-Care Infectious Disease Diagnostics & Testing Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Point-of-Care Infectious Disease Diagnostics & Testing in 2023
Figure 77. Manufacturing Process Analysis of Point-of-Care Infectious Disease Diagnostics & Testing
Figure 78. Point-of-Care Infectious Disease Diagnostics & Testing Industrial Chain
Figure 79. Methodology
Figure 80. Research Process and Data Source
Figure 1. Point-of-Care Infectious Disease Diagnostics & Testing Picture
Figure 2. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Type in 2023
Figure 4. HIV POC
Figure 5. Clostridium difficile POC
Figure 6. HBV POC
Figure 7. Pneumonia or Streptococcus associated infections
Figure 8. Respiratory syncytial virus (RSV) POC
Figure 9. HPV POC
Figure 10. Influenza/Flu POC
Figure 11. Other Infectious Disease POC
Figure 12. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 13. Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Application in 2023
Figure 14. Hospitals Picture
Figure 15. Clinics Picture
Figure 16. Home Picture
Figure 17. Assisted Living Healthcare Facilities Picture
Figure 18. Laboratories Picture
Figure 19. Others Picture
Figure 20. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 21. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 22. Global Market Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 23. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Region (2019-2030)
Figure 24. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Region in 2023
Figure 25. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Share by Players in 2023
Figure 31. Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 32. Global Top 3 Players Point-of-Care Infectious Disease Diagnostics & Testing Market Share in 2023
Figure 33. Global Top 6 Players Point-of-Care Infectious Disease Diagnostics & Testing Market Share in 2023
Figure 34. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Share by Type (2019-2024)
Figure 35. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share Forecast by Type (2025-2030)
Figure 36. Global Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Share by Application (2019-2024)
Figure 37. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share Forecast by Application (2025-2030)
Figure 38. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Type (2019-2030)
Figure 39. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Application (2019-2030)
Figure 40. North America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 42. Canada Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 43. Mexico Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 44. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Type (2019-2030)
Figure 45. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Application (2019-2030)
Figure 46. Europe Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 48. France Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 49. United Kingdom Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 50. Russia Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 51. Italy Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Region (2019-2030)
Figure 55. China Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 56. Japan Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 57. South Korea Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 58. India Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 59. Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 60. Australia Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 61. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Type (2019-2030)
Figure 62. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Application (2019-2030)
Figure 63. South America Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 65. Argentina Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 66. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Type (2019-2030)
Figure 67. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Application (2019-2030)
Figure 68. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value Market Share by Country (2019-2030)
Figure 69. Turkey Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 71. UAE Point-of-Care Infectious Disease Diagnostics & Testing Consumption Value (2019-2030) & (USD Million)
Figure 72. Point-of-Care Infectious Disease Diagnostics & Testing Market Drivers
Figure 73. Point-of-Care Infectious Disease Diagnostics & Testing Market Restraints
Figure 74. Point-of-Care Infectious Disease Diagnostics & Testing Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Point-of-Care Infectious Disease Diagnostics & Testing in 2023
Figure 77. Manufacturing Process Analysis of Point-of-Care Infectious Disease Diagnostics & Testing
Figure 78. Point-of-Care Infectious Disease Diagnostics & Testing Industrial Chain
Figure 79. Methodology
Figure 80. Research Process and Data Source
